title: Spiriva (Respimat) increases mortality by 52% in patients with COPD: time to take action.
authors.forename: Felix S F
authors.initials: FS
authors.lastname: Ram
mesh_terms: D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015201:Meta-Analysis as Topic; D009330:Nebulizers and Vaporizers; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000401:mortality; D012602:Scopolamine Derivatives / Q000008:administration & dosage / Q000009:adverse effects*; D000069447:Tiotropium Bromide
chemical_list: D018680:Cholinergic Antagonists; D012602:Scopolamine Derivatives; D000069447:Tiotropium Bromide